SCHEMBL15106904

SCHEMBL15106904

Clc1ccccc1CC=Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.51
PTGER3 P43115 1/20 0.51
PTGER2 P43116 1/20 0.51
GRIN1 Q05586 2/20 0.49
GRIN2B Q13224 2/20 0.49
TAAR1 Q96RJ0 1/20 0.45
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
RECQL P46063 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
IDO1 P14902 3/20 0.43
PNMT P11086 1/20 0.43
HPGD P15428 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24075577 0.84 PTGER4 (0.49) PTGER4PTGER3PTGER2GRIN1GRIN2B
SCHEMBL2033547 0.78 PTGER4 (0.53) PTGER4PTGER3PTGER2ALDH1A1KDM4E
SCHEMBL2033548 0.78 PTGER4 (0.53) PTGER4PTGER3PTGER2ALDH1A1KDM4E
SCHEMBL1932532 0.76 ALDH1A1 (0.55) PTGER4PTGER3PTGER2TAAR1ALDH1A1
SCHEMBL9035642 0.76 PTGER4 (0.51) PTGER4PTGER3PTGER2ALDH1A1KDM4E
SCHEMBL15106929 0.76 PTGER4 (0.51) PTGER4PTGER3PTGER2TAAR1ALDH1A1
SCHEMBL24075642 0.76 PTGER4 (0.56) PTGER4PTGER3PTGER2ALDH1A1KDM4E
SCHEMBL6546776 0.76 PTGER4 (0.56) PTGER4PTGER3PTGER2ALDH1A1KDM4E
SCHEMBL3695503 0.76 PTGER4 (0.56) PTGER4PTGER3PTGER2TAAR1ALDH1A1
SCHEMBL1932534 0.76 ALDH1A1 (0.55) PTGER4PTGER3PTGER2TAAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309188-B2 Method for allylating and vinylating aryl, heteroaryl, alkyl, and alkene halogenides using transition metal catalysis Saitigo GmbH (DE) 2016-04-12 US disclosed
US-20130184485-A1 Method for Allylating and Vinylating Aryl, Heteroaryl, Alkyl, and Alkene Halogenides Using Transition Metal Catalysis SALTIGO GMBH (DE) 2013-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184485-A1 Method for Allylating and Vinylating Aryl, Heteroaryl, Alkyl, and Alkene Halogenides Using Transition Metal Catalysis VRK2, VRK1, GRK1 PTGER4 3501/4885PTGER3 2375/4885PTGER2 2397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.